» Articles » PMID: 9034191

Cloning of a Disintegrin Metalloproteinase That Processes Precursor Tumour-necrosis Factor-alpha

Overview
Journal Nature
Specialty Science
Date 1997 Feb 20
PMID 9034191
Citations 466
Authors
Affiliations
Soon will be listed here.
Abstract

Tumour-necrosis factor-alpha (TNF-alpha) is a cytokine that contributes to a variety of inflammatory disease states. The protein exists as a membrane-bound precursor of relative molecular mass 26K which can be processed by a TNF-alpha-converting enzyme (TACE), to generate secreted 17K mature TNF-alpha. We have purified TACE and cloned its complementary DNA. TACE is a membrane-bound disintegrin metalloproteinase. Structural comparisons with other disintegrin-containing enzymes indicate that TACE is unique, with noteable sequence identity to MADM, an enzyme implicated in myelin degradation, and to KUZ, a Drosophila homologue of MADM important for neuronal development. The expression of recombinant TACE (rTACE) results in the production of functional enzyme that correctly processes precursor TNF-alpha to the mature form. The rTACE provides a readily available source of enzyme to help in the search for new anti-inflammatory agents that target the final processing stage of TNF-alpha production.

Citing Articles

CircRNA hsa_circ_0004781 promoted cell proliferation by acting as a sponge for miR-9-5p and miR-338-3p and upregulating KLF5 and ADAM17 expression in pancreatic ductal adenocarcinoma.

Lee K, Liu J, Huang W, Hung C, Liang Y Cancer Cell Int. 2025; 25(1):56.

PMID: 39972489 PMC: 11841339. DOI: 10.1186/s12935-025-03687-0.


Updates on Inflammatory Molecular Pathways Mediated by ADAM17 in Autoimmunity.

Sisto M, Lisi S Cells. 2025; 13(24.

PMID: 39768182 PMC: 11674862. DOI: 10.3390/cells13242092.


Development of a Proteomic Workflow for the Identification of Heparan Sulphate Proteoglycan-Binding Substrates of ADAM17.

Calligaris M, Spano D, Puccio M, Muller S, Bonelli S, Lo Pinto M Proteomics. 2024; 24(23-24):e202400076.

PMID: 39318062 PMC: 11648071. DOI: 10.1002/pmic.202400076.


Targeting iRhom2/ADAM17 attenuates COVID-19-induced cytokine release from cultured lung epithelial cells.

Mattos Pereira V, Thakar A, Nair S Biochem Biophys Rep. 2024; 39:101811.

PMID: 39253056 PMC: 11382212. DOI: 10.1016/j.bbrep.2024.101811.


MicroRNAs as the pivotal regulators of Temozolomide resistance in glioblastoma.

Palizkaran Yazdi M, Barjasteh A, Moghbeli M Mol Brain. 2024; 17(1):42.

PMID: 38956588 PMC: 11218189. DOI: 10.1186/s13041-024-01113-6.